Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‐label, single-dose phase I study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Expert Opinion on Biological Therapy

Topics

Medicine

Immunology

Internal Medicine

Pediatrics, Perinatology And Child Health

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1080/14712598.2024.2321360

License

CC-BY-NC-ND

Other Formats

PDF